Back
Structure Therapeutics Vs. Eli Lilly and Industry Stock Comparison
Sell
36
GPCR
Structure Therapeutics
Last Price:
39.63
Seasonality Move:
-19.39%
Buy
59
LLY
Eli Lilly and
Last Price:
917.50
Seasonality Move:
4.48%
Sell
36
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy, Sell or Hold?
- The current Structure Therapeutics [GPCR] share price is $38.99. The Score for GPCR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- GPCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Eli Lilly and (LLY)
is a Buy
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $916.42. The Score for LLY is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- LLY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GPCR Stock Price Chart
What is Structure Therapeutics's stock price today?
-
The Structure Therapeutics share price today is $38.99
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $916.42
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
GPCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.45 | Sell |
Relative Strength Index (14 RSI): | 47.46 | Sell |
Chaikin Money Flow: | 498645 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.5 - 42.7) | Sell |
Bollinger Bands (100): | (35.36 - 45.62) | Sell |
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.96 | Buy |
Relative Strength Index (14 RSI): | 52.22 | Buy |
Chaikin Money Flow: | 1377335 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (893.87 - 926.35) | Buy |
Bollinger Bands (100): | (843.7 - 937.96) | Buy |
GPCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.77 | Buy |
20-day SMA: | 40.86 | Sell |
50-day SMA: | 39.04 | Sell |
200-day SMA: | 40.58 | Sell |
8-day EMA: | 38.79 | Buy |
20-day EMA: | 39.74 | Sell |
50-day EMA: | 39.68 | Sell |
200-day EMA: | 39.82 | Sell |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 916.73 | Sell |
20-day SMA: | 907.96 | Buy |
50-day SMA: | 915.46 | Buy |
200-day SMA: | 811.14 | Buy |
8-day EMA: | 915.1 | Buy |
20-day EMA: | 911.43 | Buy |
50-day EMA: | 904.71 | Buy |
200-day EMA: | 808.39 | Buy |
Structure Therapeutics Earnings Growth & GPCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.07 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $4.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.10 per share, and an increase next year of $9.43 per share.
Structure Therapeutics Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Eli Lilly and Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |